EYEWASH- water solution 
MWI

----------

APEXA EYEWASH

Drug Facts

Active ingredient

Purified water 98.3%

Purpose

Eyewash

Use

For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Warnings

For external use only

Do not use

  • if you experience any open wounds in or near the eyes and obtain immediate medical treatment
  • if solution changes color or becomes cloudy

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • do not reuse
  • once opened, discard

Stop use and ask a doctor if you experience

  • changes in vision
  • eye pain
  • condition worsens or persists
  • continued redness or irritation of the eye

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.

Other information

Inactive ingredients

boric acid, sodium borate, sodium chloride

Questions ?

Call 888-628-0581

Principal Display Panel Text for Container Label:

NDC 13985-609-04

Ophthalmic

Solution

Eyewash

Purified Water, 98.3%

STERILE SOLUTION

Single Use

APEXA logo

AP 704011

4 fl.oz. (118 mL)

Principal Display Panel Text for Container Label
EYEWASH 
water solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13985-609
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER929 g  in 946 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13985-609-041 in 1 BOTTLE03/25/2015
1118 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02230502/23/2015
Labeler - MWI (019926120)
Registrant - Akorn Operating Company LLC (117693100)
Establishment
NameAddressID/FEIBusiness Operations
Niagara Pharmaceuticals, Inc.205477792manufacture(13985-609)

Revised: 10/2020
Document Id: e98fc587-9a9e-48c0-beeb-6d30b027f0af
Set id: 1fa0cc05-37ce-4d61-8060-fd89a5d449d2
Version: 4
Effective Time: 20201026
 
MWI